Updated Jul 16, 2026
German Christopher Paul has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.52M.
Christopher Paul German is the Corporate Controller and Chief Accounting Officer at Rhythm Pharmaceuticals, Inc. He has been involved in the company's financial operations and reporting. His role focuses on overseeing the accounting functions within the biopharmaceutical company.
| Role | Corporate Controller & CAO |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 4.6K | $92.21 | $428K |
| 2026-05-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.4K | $17.97 | $25K |
| 2026-05-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.3K | $49.23 | $66K |
| 2026-05-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.7K | $56.69 | $96K |
| 2026-03-06 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 5.6K | $89.56 | $503K |
| 2026-03-06 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.5K | $17.97 | $27K |
| 2026-03-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 342 | $94.94 | $32K |
| 2026-03-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.2K | — | |
| 2026-02-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 1.1K | $108.99 | $124K |
| 2026-02-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 3.6K | — | |
| 2025-08-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 1.5K | $95.00 | $142K |
| 2025-08-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 500 | $49.23 | $25K |
| 2025-08-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.0K | $17.97 | $18K |
| 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 1.9K | $85.00 | $157K |
| 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 2.0K | $76.75 | $151K |
| 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 850 | $49.23 | $42K |
| 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 2.0K | $17.97 | $36K |
| 2025-06-10 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 2.1K | $67.19 | $139K |
| 2025-06-10 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 1.1K | $17.97 | $19K |
Christopher Paul German is the Corporate Controller and Chief Accounting Officer at Rhythm Pharmaceuticals, Inc. He has been involved in the company's financial operations and reporting. His role focuses on overseeing the accounting functions within the biopharmaceutical company.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($1.52M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live German Christopher Paul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.